PLAY PODCASTS
EP442: A Short Rumination on Saving Money, Except Not Saving Money. Oncology Side Effect Management as a Case Study, With Andreas Mang
Episode 442

EP442: A Short Rumination on Saving Money, Except Not Saving Money. Oncology Side Effect Management as a Case Study, With Andreas Mang

Relentless Health Value ยท Stacey Richter

June 27, 202418m 51s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In Episode 442 of 'Relentless Health Value,' host Stacey Richter shares an intriguing outtake from a previous episode featuring Andreas Mang, senior managing director at Blackstone, discussing the critical issue of cost management in oncology side effect treatment.

The conversation delves into the inefficiencies and patient harms caused by inadequate side effect management, particularly dehydration due to chemotherapy, and the resulting financial burdens on employers, taxpayers, and patients.

Stacey explores the importance of a value-based mindset in drug purchasing, integrating oncology care, and the potential financial and health benefits of better side effect management. She highlights various expert opinions and studies supporting these points, encouraging listeners to reconsider their approach to healthcare cost structures and patient care protocols.

=== LINKS === ๐Ÿ”— Show Notes with all mentioned links: https://cc-lnk.com/EP442

๐Ÿ”— Healthcare Industry Acronyms and Terms https://relentlesshealthvalue.com/healthcare-acronymns

โœ‰๏ธ Enjoy this podcast? Subscribe to the free weekly newsletter: https://relentlesshealthvalue.com/join-the-relentless-tribe

๐Ÿซ™ Support the podcast with a small donation to the Tip Jar: https://relentlesshealthvalue.com/join-the-relentless-tribe

๐Ÿ“บ Subscribe to our YouTube channel https://www.youtube.com/@RelentlessHealthValue

๐ŸŽค Listen on Apple Podcasts https://podcasts.apple.com/us/podcast/feed/id892082003?ls=1

๐ŸŽค Listen on Spotify https://open.spotify.com/show/6UjgzI7bScDrWvZEk2f46b

=== CONNECT WITH THE RHV TEAM === โœญ LinkedIn https://www.linkedin.com/company/relentless-health-value/ โœญ Threads https://www.threads.net/@relentlesshealthvalue/ โœญ Bluesky https://bsky.app/profile/relentleshealth.bsky.social โœญ X https://twitter.com/relentleshealth/

01:12 Andreas Mang on oncology medication side effect management.

03:12 Mark Lewis, MD's Tweet.

03:39 Celena Latham's response.

04:22 How integrative oncology can save money and what it looks like.

04:47 EP157 with Ethan Basch, MD.

06:20 Why PBMs saving money doesn't necessarily mean savings for employers and payers.

07:36 EP435 with Dan Mendelson.

08:20 EP372 with Cora Opsahl.

08:40 EP331 with Al Lewis.

09:50 Stacey's second rumination.

10:19 Why having a value mindset when purchasing is a thing.

10:42 Stacey's third rumination.

12:03 EP370 with Erik Davis and Autumn Yongchu.

13:07 Why FFS does not pay or pay adequately for side effect management.

14:31 Stacey's final rumination.

17:08 Summarizing Stacey's four ruminations on this topic.